Microfluidic tumor-on-chip systems for breast cancer research

Breast cancer is one of the most frequent malignant tumors among women worldwide. In the early stage of breast cancer, neoplastic epithelial cells accumulate in the lumen of mammary duct that form pre-invasive cancerous lesions known as ductal carcinoma in situ (DCIS).